Site notifications

Sub menu

 

 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset for information on the evaluation of prescription medicines.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

1125 result(s) found, displaying 851 to 875

  • AusPAR: Linagliptin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Linagliptin

  • AusPAR: Terlipressin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Terlipressin

  • AusPAR: Vismodegib

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Vismodegib

  • AusPAR: IVIg

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for IVIg

  • AusPAR: Pitavastatin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Pitavastatin

  • AusPAR: Rituximab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Rituximab

  • AusPAR: Aflibercept (rch)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Aflibercept (rch)

  • AusPAR: C1 esterase inhibitor

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for C1 esterase inhibitor

  • AusPAR: Everolimus

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Everolimus

  • AusPAR: Azacitidine

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Azacitidine

  • AusPAR: Lixisenatide

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Lixisenatide

  • AusPAR: Golimumab (rmc)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Golimumab (rmc)

  • AusPAR: Zonisamide

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Zonisamide

  • AusPAR: Micafungin (as sodium)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Micafungin (as sodium)

  • AusPAR: Tadalafil

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Tadalafil

  • AusPAR: Vandetanib

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Vandetanib

  • AusPAR: Ingenol mebutate

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Ingenol mebutate

  • AusPAR: Mycophenolate sodium

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Mycophenolate sodium